El 4-Pro-MET (4-propioniloxilo-N-metil-N-etiltriptamina) es un compuesto triptamínico sintético con fórmula molecular C15H20N2O2 y un peso molecular de 274,364 g/mol. Como profármaco del 4-HO-MET (metocina), la sustancia se encuentra en el centro del debate sobre química de investigación. ¿Cuál es la situación legal en Alemania, Austria y Suiza a fecha de abril de 2026? Este artículo explica por qué el 4-Pro-MET no está sujeto ni a la Ley de Estupefacientes ni a la Ley de Nuevas Sustancias Psicoactivas, y desarrolla la lógica química que fundamenta esta clasificación.

Sí – a fecha de abril de 2026, el 4-Pro-MET no está incluido en Alemania ni en la Ley de Estupefacientes (BtMG) ni en la Ley de Nuevas Sustancias Psicoactivas (NpSG). Posesión, adquisición, venta: sin restricciones en materia de estupefacientes. Esta evaluación se basa en un análisis de los textos legales vigentes y las definiciones de grupos de sustancias.

En la comunidad de química de investigación, el 4-Pro-MET está considerado uno de los pocos compuestos triptamínicos de libre adquisición en Alemania. Sin embargo, la delimitación respecto al NpSG es sutil —depende de un único detalle estructural—. Lo analizamos paso a paso.

El mensaje clave si se desea actuar con plenas garantías: la situación legal es actualmente clara. El 4-Pro-MET no está sujeto en Alemania a ningún control en materia de estupefacientes —ni como estupefaciente ni como sustancia incluida en el NpSG—. No obstante, verifique la normativa vigente antes de cualquier pedido, ya que las regulaciones cambian. Actualizamos este artículo ante cualquier modificación legal e indicamos la fecha de la última revisión.

The BtMG does not list 4-Pro-MET by name in any of its three schedules (Anlagen I�III). Germany's narcotics law relies on explicit compound listings, not structural group bans. As of April 2026, the BtMG Anlage I contains approximately 640 individually named substances. 4-Propionyloxy-N-methyl-N-ethyltryptamine isn't among them.

How the BtMG Schedules Work

Three categories divide the controlled substances: Anlage I (non-prescribable narcotics), Anlage II (marketable but prescription-only), and Anlage III (prescription narcotics). New entries are added through amendments proposed by the Federal Ministry of Health, typically after a risk assessment by the BfArM (Federal Institute for Drugs and Medical Devices). From initial evaluation to gazette publication, this process can take 12–24 months.

Several tryptamines are listed – psilocybin, psilocin, DMT, and 5-MeO-DMT among them – but the 4-substituted propionyloxy variants have not been individually scheduled. And here's the key distinction: 4-AcO-DMT was added to Anlage I in 2022, yet that was a substance-specific listing. It doesn't automatically extend to other 4-acyloxy tryptamines with different N-alkyl substitution patterns.

Could 4-Pro-MET Be Added to the BtMG?

In theory, yes. The BfArM monitors novel psychoactive compounds through the EU Early Warning System, which reported over 50 new synthetic compounds in 2025 alone. But scheduling typically follows evidence of widespread use or documented harm. Community survey data suggests 4-Pro-MET usage stays niche – estimated at fewer than 5,000 users across the DACH region – which likely lowers its scheduling priority.

The NpSG, enacted in November 2016, works differently. Instead of listing individual compounds, it defines entire structural groups. For tryptamines, the relevant definition is Substance Group 5.1 (Indol-3-alkylamines). It specifies an indole core structure and exhaustively lists the permitted substituents at positions 4–7 of the indole ring (the so-called Rn substituents).

Why 4-Pro-MET Falls Outside the NpSG

The Rn substituent list in Substance Group 5.1 reads: ?Hydrogen, fluorine, chlorine, bromine, iodine, alkyl (up to C4), alkyloxy (up to C10), benzyloxy, carboxamido, methoxy, trialkylsilyl, trifluoromethyl, trifluoromethoxy, acetoxy, hydroxy, and methylthio groups.? Only acetoxy (the acetic acid ester, C2) is listed – propionyloxy (the propionic acid ester, C3) is absent. Because 4-Pro-MET carries a propionyloxy group at position 4 of the indole ring, and this substituent isn't among the enumerated Rn options, the substance falls outside the definition. The 6th NpSG Amendment (published December 1, 2025; effective April 12, 2026) added trialkylsilyl, trifluoromethyl, and trifluoromethoxy to the list but did not add propionyloxy.

What the NpSG Actually Prohibits

The NpSG criminalizes trading, manufacturing for trade, or importing covered substances – but personal possession is not an offense under this law (unlike the BtMG). So even if 4-Pro-MET were reclassified in a future amendment, legal consequences would apply to commercial activity, not personal possession. One caveat: the Bundesgesundheitsministerium can close this gap at any time by adding propionyloxy or a broader ?alkanoyloxy? term to the Rn list.

Las leyes cambian. Así de sencillo. El Ministerio Federal de Salud revisa periódicamente si nuevas sustancias deben incluirse en los anexos del BtMG. La última gran actualización del BtMG tuvo lugar en junio de 2024 —se añadieron varios cannabinoides sintéticos y un opioide de benzimidazol—. El próximo ciclo de revisión se espera para el segundo semestre de 2026.

Posibles escenarios para 2026 y más allá

Varios desarrollos podrían influir en la situación legal. Los cambios legislativos en Alemania requieren habitualmente entre 6 y 18 meses de tramitación —desde la recomendación del comité de expertos, pasando por el proyecto, hasta su publicación en el Boletín Oficial Federal—. Por tanto, no hay cambios de la noche a la mañana.

• Ampliación del BtMG: una inclusión nominal del 4-Pro-MET es teóricamente posible, pero requiere una recomendación del comité de expertos. Escasa presencia en el mercado, ausencia de informes de incidentes sanitarios —improbable a corto plazo—. La EMCDDA/EUDA no ha incluido hasta la fecha el 4-Pro-MET en su sistema de alerta temprana (EU Early Warning System).
• Reforma del NpSG: una ampliación de las definiciones de grupos de sustancias podría incluir en el futuro triptaminas sin cadena lateral oxo. Los debates al respecto se llevan desarrollando a nivel europeo desde 2023, en el marco del Reglamento Europeo sobre Drogas. Esto cambiaría completamente la situación legal del 4-Pro-MET —pero por el momento no está decidido—.
• Armonización a escala europea: el Reglamento europeo sobre drogas (Reglamento 2023/2127) podría influir a medio plazo en las regulaciones nacionales. La EUDA monitorea continuamente las nuevas sustancias y emite recomendaciones a los Estados miembros. Hasta la fecha, la EUDA no ha realizado ninguna evaluación de riesgos sobre el 4-Pro-MET.
• Modelos de prohibición general: algunos Estados miembros de la UE (Irlanda, Reino Unido) aplican prohibiciones generales. En Alemania, los expertos jurídicos lo consideran improbable —las reservas constitucionales relativas a la taxatividad del derecho penal hablan en su contra—.

Nuestra recomendación: manténgase informado. Actualizamos este artículo ante cualquier modificación relevante e indicamos la fecha de revisión. Suscríbase a nuestra newsletter para recibir notificaciones sobre cambios normativos.

4-Pro-MET is legal in Germany right now. That could change. The regulatory environment around novel psychoactive substances moves, and several factors could trigger reclassification during 2026 or later.

EU-Level Early Warning System

The EMCDDA (now EUDA – European Union Drugs Agency since July 2024) monitors novel substances through its Early Warning System. If 4-Pro-MET gets formally notified and a risk assessment is triggered, EU member states may be prompted to act. In 2025, the EUDA issued risk assessments for 4 tryptamine-related compounds – none of which were 4-Pro-MET. On average, the gap from EUDA risk assessment to national scheduling runs about 18 months across EU member states.

German Legislative Calendar

Germany's BtMG amendment process (Betäubungsmittelrechts-Änderungsverordnung) typically runs 1–2 times per year. The most recent amendment (38th BtMÄndV) entered into force in October 2025 and did not include any 4-propionyloxy tryptamines. Next expected window: Q3/Q4 2026. NpSG structural group updates are a heavier lift – they require full Bundestag legislation, which is slower and politically harder to push through.

Signals to Watch

Scheduling may be approaching if you see: EUDA formal notification of 4-Pro-MET, BfArM public consultations mentioning propionyloxy tryptamines, seizure reports from German customs (Zoll), or increased media coverage. As of April 2026, none of these triggers have been activated for 4-Pro-MET.

Ordering 4-Pro-MET legally in Germany comes down to choosing a vendor that provides analytical verification and ships from within the EU.

Vendor Quality Indicators

A trustworthy supplier should include third-party lab analysis (Certificate of Analysis / CoA) with each batch, confirming identity and purity via HPLC and NMR. Vendors providing CoA documentation average above 98% product purity, compared to roughly 85–92% for unverified sources. Stick with EU-based shipping to avoid customs headaches – shipments from outside the EU face a roughly 15–20% seizure rate according to harm reduction community reports from 2025.

Payment and Privacy

Most vendors accept bank transfer (SEPA), cryptocurrency, and sometimes credit cards. Discreet packaging and GDPR compliance are baseline expectations for any legitimate EU-based research chemical supplier. According to a 2025 European research chemical market survey, approximately 73% of transactions in the DACH region are completed via bank transfer.